Barry M. Salzman serves as Executive at Checkpoint Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Barry M. Salzman has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 14, 2024 involved receiving (via award) 32,051 shares valued at $0.
Barry M. Salzman currently holds 67,174 shares of Checkpoint Therapeutics, Inc. (CKPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barry M. Salzman has been a net neutral trader of CKPT stock. They have purchased $0 and sold $0 worth of shares.
Barry M. Salzman's most recent insider trade was on May 14, 2024, when they sold 32,051 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 13, 2023 | CKPT | $0 | Award | 17,483 | $N/A | Discretionary |
| Jun 16, 2022 | CKPT | $0 | Award | 47,619 | $N/A | Discretionary |
| Jun 10, 2021 | CKPT | $0 | Award | 16,502 | $N/A | Discretionary |
| Jun 5, 2020 | CKPT | $0 | Award | 24,390 | $N/A | Discretionary |
| Jun 13, 2019 | CKPT | $0 | Award | 11,442 | $N/A | Discretionary |
| Jun 14, 2018 | CKPT | $0 | Award | 16,448 | $N/A | Discretionary |
| Jun 15, 2017 | CKPT | $0 | Award | 10,000 | $N/A | Discretionary |